Alcoholic Cirrhosis Clinical Trial
Official title:
EUS Based Prevalence of Chronic Pancreatitis in Alcoholic Cirrhosis: Any Difference Between Alcoholic and Non-alcoholic Patients
Alcohol is the common precipitating factor for both cirrhosis of liver as well as alcohol related chronic pancreatitis. However, in real life clinical setting, clinicians do not frequently see many cases of symptomatic pancreatitis in patients who present with features of cirrhosis of liver. On the contrary, in some patients presenting with alcohol related chronic pancreatitis, evidence of cirrhosis of liver is observed on imaging without other clinical features of cirrhosis.
The data on exact incidence of chronic pancreatitis in patients with alcoholic cirrhosis is scarce and there are no data to support or refute as to whether the incidence is same between alcoholic cirrhosis or cirrhosis due to any other cause. The co-existence of cirrhosis and chronic pancreatitis in alcoholics vary between 0.04 - 6%. However, till now no study has been conducted to evaluate the incidence of CP in patients with alcoholic cirrhosis of liver. In this study, the investigators propose to assess the incidence of chronic pancreatitis in patients of ethanol related cirrhosis of liver and compare the same with patients of cryptogenic liver cirrhosis and hepatitis B and C related liver cirrhosis. This would be one of the few studies till date, to use EUS as the diagnostic modality. The patients of cirrhosis would be categorized based on their Child Pugh criteria into three categories. All these patients would undergo EUS at the Institute and chronic pancreatitis screening would be considered positive if they fulfill the Rosemont criteria for chronic pancreatitis. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04106518 -
Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease
|
||
| Completed |
NCT01065233 -
Pangenomic Study During Alcoholic Cirrhosis
|
||
| Recruiting |
NCT04250259 -
SAMe Trial for Patients With Alcoholic Cirrhosis
|
Phase 2 | |
| Active, not recruiting |
NCT01213927 -
National Cohort of Uncomplicated Alcoholic Cirrhosis
|
||
| Completed |
NCT00388323 -
Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human
|
N/A | |
| Terminated |
NCT01342705 -
Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis
|
Phase 3 | |
| Recruiting |
NCT04689152 -
Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis
|
Phase 3 | |
| Recruiting |
NCT05155657 -
Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells
|
Phase 1 | |
| Terminated |
NCT03534141 -
Mild Hypothermia and Acute Kidney Injury in Liver Transplantation
|
N/A | |
| Completed |
NCT02072746 -
Zinc Supplementation in Alcoholic Cirrhosis
|
N/A | |
| Completed |
NCT00827723 -
Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma
|
||
| Completed |
NCT01756794 -
Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatment
|
N/A | |
| Recruiting |
NCT05093881 -
Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
|
N/A | |
| Terminated |
NCT03508388 -
Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis
|
||
| Completed |
NCT02326103 -
Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis
|
Phase 0 | |
| Terminated |
NCT00188045 -
Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients
|
Phase 4 | |
| Withdrawn |
NCT04070508 -
Early Detection of Alcoholic Liver Disease
|
||
| Recruiting |
NCT04363424 -
Alcohol Biomarker Study
|